Market Research

North America Influenza Drug Market

Best Price Guarantee Length Publisher Published Date SKU
from $3,500 178 Pages Data Bridge Market Research April, 2024 DAABD18813145
Best Price Guarantee
Price from $3,500
Length 178 Pages
Publisher Data Bridge Market Research
Published Date April, 2024
SKU DAABD18813145

North America Influenza Drug Market


North America Influenza drug market is expected to reach USD 5,435,923.95 thousand by 2031, from USD 2,955,221.99 thousand in 2023, growing at a CAGR of 8.1% in the forecast period of 2023 to 2031..
Market Segmentation:
North America Influenza Drug Market, By Type (Influenza A, Influenza B, and Influenza C), Treatment (Vaccine and Drugs), Route of Administration (Oral, Intramuscular, Intradermal, Intranasal, and Intravenous), Age (Pediatrics and Adults), End User (Hospitals, and Home Care), Distribution Channel (Direct Tenders and Retail Sales), Country (U.S., Canada and Mexico) - Industry Trends & Forecast to 2031

Some of the major factors contributing to the growth of the North America influenza drug market are:

• Increasing prevalence rate of influenza
• Government initiatives and vaccination programs
• Advancements in medical research and technology

Market Players:

The key market players for North America influenza drug market are listed below:

• Ambu A/S
• GSK plc.
• Sanofi S.A.
• CSL,
• Astrazeneca Plc
• F. Hoffmann-La Roche Ltd
• Viatris Inc.,
• Abbott
• Amneal Pharmaceuticals LLC.
• AbbVie Inc
• BioCryst Pharmaceuticals Inc.
• Lupin
• Zydus Pharmaceuticals, Inc.
• Macleods Pharmaceuticals Ltd.
• Viatris Inc.
• DAIICHI SANKYO COMPANY
• LIMITED, Cipla Inc.
• Shionogi & Co., Ltd.
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• NATCO Pharma Limited
• Alvogen

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Influenza Drug Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 DBMR Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 DBMR Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter's Five Forces Model
5 Market Overview
5.1 Drivers
5.1.1 Increasing Prevalence Rate Of Influenza
5.1.2 Government Initiatives And Vaccination Programs
5.1.3 Advancements In Medical Research And Technology
5.1.4 Continous Launches Of The New Drugs And Vaccine
5.2 Restraints
5.2.1 Adverse Effect Of Anti-influenza Drugs
5.2.2 Counterfeit Of Drug In Pharmaceutical Industry
5.3 Opportunities
5.3.1 Integration Of Telemedicine And Digital Health Solutions
5.3.2 Development Of Combination Therapies
5.3.3 Advancing Universal Vaccines
5.4 Challenges
5.4.1 Emergence Of Drug Resistant Strains
5.4.2 Inefficiency In The Supply Chain Of Vaccine
6 North America Influenza Drug Market, By Type
6.1 Overview
6.2 Influenza A
6.3 Influenza B
6.4 Influenza C
7 North America Influenza Drug Market, By Treatment
7.1 Overview
7.2 Vaccines
7.3 Drugs
8 North America Influenza Drug Market, By Route Of Administration
8.1 Overview
8.2 Oral
8.3 Intramuscular
8.4 Intradermal
8.5 Intranasal
8.6 Intravenous
9 North America Influenza Drug Market, By Age
9.1 Overview
9.2 Pediatrics
9.3 Adults
10 North America Influenza Drug Market, By End User
10.1 Overview
10.2 Hospitals
10.3 Homecare
11 North America Influenza Drug Market, By Distribution Channel
11.1 Overview
11.2 Direct Tender
11.3 Retail Sales
12 North America Influenza Drug Market, By Country
12.1 North America
12.1.1 U.S.
12.1.2 Mexico
12.1.3 Canada
13 North America Influenza Drug Market: Company Landscape
13.1 Company Share Analysis: North America
14 Swot Analysis
15 Company Profiles
15.1 Gsk Plc.
15.1.1 Company Snapshot
15.1.2 Revenue Analysis
15.1.3 Company Share Analysis
15.1.4 Product Portfolio
15.1.5 Recent Developments
15.2 Sanofi
15.2.1 Company Snapshot
15.2.2 Revenue Analysis
15.2.3 Company Share Analysis
15.2.4 Product Portfolio
15.2.5 Recent Developments
15.3 Csl
15.3.1 Company Snapshot
15.3.2 Revenue Analysis
15.3.3 Company Share Analysis
15.3.4 Product Portfolio
15.3.5 Recent Developments
15.4 Astrazeneca
15.4.1 Company Snapshot
15.4.2 Revenue Analysis
15.4.3 Company Share Analysis
15.4.4 Product Portfolio
15.4.5 Recent Development
15.5 F. Hoffmann-la Roche Ltd.
15.5.1 Company Snapshot
15.5.1 Revenue Analysis
15.5.2 Company Share Analysis
15.5.3 Product Portfolio
15.5.4 Recent Development
15.6 Abbott
15.6.1 Company Snapshot
15.6.2 Revenue Analysis
15.6.3 Product Portfolio
15.6.4 Recent Development
15.7 Abbvie Inc.
15.7.1 Company Snapshot
15.7.2 Revenue Analysis
15.7.3 Product Portfolio
15.7.4 Recent Development
15.8 Alvogen
15.8.1 Company Snapshot
15.8.2 Product Portfolio
15.8.3 Recent Development
15.9 Amneal Pharmaceuticals Llc.
15.9.1 Company Snapshot
15.9.2 Revenue Analysis
15.9.3 Product Portfolio
15.9.4 Recent Development
15.10 Biocryst Pharmaceuticals, Inc.
15.10.1 Company Snapshot
15.10.2 Revenue Analysis
15.10.3 Product Portfolio
15.10.4 Recent Development
15.11 Cipla Inc.
15.11.1 Company Snapshot
15.11.2 Revenue Analysis
15.11.3 Product Portfolio
15.11.4 Recent Development
15.12 Daiichi Sankyo Company, Limited
15.12.1 Company Snapshot
15.12.2 Revenue Analysis
15.12.3 Product Portfolio
15.12.4 Recent Development
15.13 Lupin
15.13.1 Company Snapshot
15.13.2 Revenue Analysis
15.13.3 Product Portfolio
15.13.4 Recent Development
15.14 Macleods Pharmaceuticals Ltd.
15.14.1 Company Snapshot
15.14.2 Product Portfolio
15.14.3 Recent Development
15.15 Natco Pharma Limited
15.15.1 Company Snapshot
15.15.2 Revenue Analysis
15.15.3 Product Portfolio
15.15.4 Recent Development
15.16 Shionogi & Co., Ltd.
15.16.1 Company Snapshot
15.16.2 Revenue Analysis
15.16.3 Product Portfolio
15.16.4 Recent Development
15.17 Takeda Pharmaceutical Company Limited
15.17.1 Company Snapshot
15.17.2 Revenue Analysis
15.17.3 Product Portfolio
15.17.4 Recent Development
15.18 Teva Pharmaceutical Industries Ltd.
15.18.1 Company Snapshot
15.18.2 Revenue Analysis
15.18.3 Product Portfolio
15.18.4 Recent Development
15.19 Viatris Inc.
15.19.1 Company Snapshot
15.19.2 Revenue Analysis
15.19.3 Product Portfolio
15.19.4 Recent Development
15.20 Zydus Pharmaceuticals, Inc.
15.20.1 Company Snapshot
15.20.2 Revenue Analysis
15.20.3 Product Portfolio
15.20.4 Recent Developments
16 Questionnaire
17 Related Reports
Table 1 North America Influenza Drug Market, By Type, 2022-2031 (Usd Thousand)
Table 2 North America Influenza A In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 3 North America Influenza B In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 4 North America Influenza C In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 5 North America Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 6 North America Influenza A In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 7 North America Drugs In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 8 North America Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 9 North America Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 10 North America Trivalentin Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 11 North America Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 12 North America Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 13 North America Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand)
Table 14 North America Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 15 North America Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 16 North America Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 17 North America Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand)
Table 18 North America Oral Market, By Region, 2022-2031 (Usd Thousand)
Table 19 North America Intramuscular In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 20 North America Intradermal In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 21 North America Intranasal In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 22 North America Intravenous In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 23 North America Influenza Drug Market, By Age, 2022-2031 (Usd Thousand)
Table 24 North America Pediatrics Market, By Region, 2022-2031 (Usd Thousand)
Table 25 North America Adults In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 26 North America Influenza Drug Market, By End User, 2022-2031 (Usd Thousand)
Table 27 North America Hospitals In North America Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 28 North America Homecare In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 29 North America Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 30 North America Direct Tender In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 31 North America Retail Sales In Influenza Drug Market, By Region, 2022-2031 (Usd Thousand)
Table 32 North America Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 33 North America Influenza Drug Market, By Country, 2022-2031 (Usd Thousand)
Table 34 North America Influenza Drug Market, By Type, 2022-2031 (Usd Thousand)
Table 35 North America Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 36 North America Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 37 North America Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 38 North America Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 39 North America Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 40 North America Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 41 North America Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand)
Table 42 North America Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 43 North America Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 44 North America Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 45 North America Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand)
Table 46 North America Influenza Drug Market, By Age, 2022-2031 (Usd Thousand)
Table 47 North America Influenza Drug Market, By End User, 2022-2031 (Usd Thousand)
Table 48 North America Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 49 North America Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 50 U.S. Influenza Drug Market, By Type, 2022-2031 (Usd Thousand)
Table 51 U.S. Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 52 U.S. Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 53 U.S. Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 54 U.S. Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 55 U.S. Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 56 U.S. Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 57 U.S. Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand)
Table 58 U.S. Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 59 U.S. Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 60 U.S. Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 61 U.S. Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand)
Table 62 U.S. Influenza Drug Market, By Age, 2022-2031 (Usd Thousand)
Table 63 U.S. Influenza Drug Market, By End User, 2022-2031 (Usd Thousand)
Table 64 U.S. Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 65 U.S. Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 66 Mexico Influenza Drug Market, By Type, 2022-2031 (Usd Thousand)
Table 67 Mexico Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 68 Mexico Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 69 Mexico Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 70 Mexico Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 71 Mexico Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 72 Mexico Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 73 Mexico Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand)
Table 74 Mexico Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 75 Mexico Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 76 Mexico Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 77 Mexico Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand)
Table 78 Mexico Influenza Drug Market, By Age, 2022-2031 (Usd Thousand)
Table 79 Mexico Influenza Drug Market, By End User, 2022-2031 (Usd Thousand)
Table 80 Mexico Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 81 Mexico Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 82 Canada Influenza Drug Market, By Type, 2022-2031 (Usd Thousand)
Table 83 Canada Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 84 Canada Vaccines In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 85 Canada Quadrivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 86 Canada Trivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 87 Canada Bivalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 88 Canada Monovalent In Influenza Drug Market, By Product, 2022-2031 (Usd Thousand)
Table 89 Canada Vaccines In Influenza Drug Market, By Technology, 2022-2031 (Usd Thousand)
Table 90 Canada Inactivated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 91 Canada Live Attenuated In Influenza Drug Market, By Valency, 2022-2031 (Usd Thousand)
Table 92 Canada Drugs In Influenza Drug Market, By Treatment, 2022-2031 (Usd Thousand)
Table 93 Canada Influenza Drug Market, By Route Of Administration, 2022-2031 (Usd Thousand)
Table 94 Canada Influenza Drug Market, By Age, 2022-2031 (Usd Thousand)
Table 95 Canada Influenza Drug Market, By End User, 2022-2031 (Usd Thousand)
Table 96 Canada Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Table 97 Canada Retail Sales In Influenza Drug Market, By Distribution Channel, 2022-2031 (Usd Thousand)
Figure 1 North America Influenza Drug Market: Segmentation
Figure 2 North America Influenza Drug Market: Data Triangulation
Figure 3 North America Influenza Drug Market: Droc Analysis
Figure 4 North America Influenza Drug Market: North America Vs Regional Market Analysis
Figure 5 North America Influenza Drug Market: Company Research Analysis
Figure 6 North America Influenza Drug Market: Interview Demographics
Figure 7 North America Influenza Drug Market: Market Application Coverage Grid
Figure 8 North America Influenza Drug Market: DBMR Market Position Grid
Figure 9 North America Influenza Drug Market: Vendor Share Analysis
Figure 10 North America Influenza Drug Market: Segmentation
Figure 11 Government Initiatives And Vaccination Programs Is Driving The Growth Of The North America Influenza Drug Market From 2024 To 2031
Figure 12 The Influenza A Segment Is Expected To Account For The Largest Share Of The North America Influenza Drug Market In 2024 And 2031
Figure 13 Drivers, Restraints, Opportunities And Challenges Of North America Influenza Drugs Market
Figure 14 North America Influenza Drug Market: By Type, 2023
Figure 15 North America Influenza Drug Market: By Type, 2024-2031 (Usd Thousand)
Figure 16 North America Influenza Drug Market: By Type, Cagr (2024-2031)
Figure 17 North America Influenza Drug Market: By Type, Lifeline Curve
Figure 18 North America Influenza Drug Market: By Treatment, 2023
Figure 19 North America Influenza Drug Market: By Treatment, 2024-2031 (Usd Thousand)
Figure 20 North America Influenza Drug Market: By Cagr (2024-2031)
Figure 21 North America Influenza Drug Market: By Treatment, Lifeline Curve
Figure 22 North America Influenza Drug Market : By Route Of Administration, 2023
Figure 23 North America Influenza Drug Market : By Route Of Administration, 2024-2031 (Usd Thousand)
Figure 24 North America Influenza Drug Market : By Route Of Administration, Cagr (2024-2031)
Figure 25 North America Influenza Drug Market : By Route Of Administration, Lifeline Curve
Figure 26 North America Influenza Drug Market : By Age, 2023
Figure 27 North America Influenza Drug Market : By Age, 2024-2031 (Usd Thousand)
Figure 28 North America Influenza Drug Market : By Age, Cagr (2024-2031)
Figure 29 North America Influenza Drug Market : By Age, Lifeline Curve
Figure 30 North America Influenza Drug Market : By End User, 2023
Figure 31 North America Influenza Drug Market : By End User, 2024-2031 (Usd Thousand)
Figure 32 North America Influenza Drug Market : By End User, Cagr (2024-2031)
Figure 33 North America Influenza Drug Market : By End User, Lifeline Curve
Figure 34 North America Influenza Drug Market: By Distribution Channel, 2024-2031 (Usd Thousand)
Figure 35 North America Influenza Drug Market: By Distribution Channel, 2023
Figure 36 North America Influenza Drug Market: By Distribution Channel, Cagr (2024-2031)
Figure 37 North America Influenza Drug Market: By Distribution Channel, Lifeline Curve
Figure 38 North America Influenza Drug Market: Snapshot (2023)
Figure 39 North America Influenza Drug Market: Company Share 2023 (%)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings